Scinai Immunotherapeutics annual free cash flow
2015
2016
2017
2018
2019
2020
2021
Scinai Immunotherapeutics Free Cash Flow (FCF) History (SCNI)
Scinai Immunotherapeutics reported −₪24.9M in free cash flow for fiscal 2021, an increase of ₪53.8M from the previous fiscal year.
View full Scinai Immunotherapeutics company overviewScinai Immunotherapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2021 | 2021-12-31 | −₪24.9M | ₪53.8M | — | — |
| 2020 | 2020-12-31 | −₪78.7M | ₪5.8M | — | — |
| 2019 | 2019-12-31 | −₪84.5M | −₪3.6M | — | — |
| 2018 | 2018-12-31 | −₪80.9M | −₪66.4M | — | — |
| 2017 | 2017-12-31 | −₪14.6M | −₪4.9M | — | — |
| 2016 | 2016-12-31 | −₪9.7M | ₪628,000 | — | — |
| 2015 | 2015-12-31 | −₪10.3M | — | — | — |
Scinai Immunotherapeutics quarterly free cash flow
Q2.19
Q3.19
Q2.20
Q3.20
Q2.21
Q3.21
Q2.22
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2022 | 2022-06-30 | −₪10.4M | ₪2.7M | — | — |
| Q3 2021 | 2021-09-30 | −₪6.2M | ₪20.9M | — | — |
| Q2 2021 | 2021-06-30 | −₪8.0M | ₪14.9M | — | — |
| Q3 2020 | 2020-09-30 | −₪13.7M | — | — | — |
| Q2 2020 | 2020-06-30 | −₪13.2M | — | — | — |
| Q3 2019 | 2019-09-30 | −₪27.1M | — | — | — |
| Q2 2019 | 2019-06-30 | −₪22.9M | — | — | — |
Scinai Immunotherapeutics free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −₪9.7M to −₪24.9M, a net decrease of ₪15.2M. Scinai Immunotherapeutics's latest reported quarter, Q2 2022, generated −₪10.4M in free cash flow, an increase of ₪2.7M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Scinai Immunotherapeutics filings at SEC.gov ↗